Advertisement
American Journal of Kidney Diseases

Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences

  • Anthony J. Bleyer
    Correspondence
    Address reprint requests to Anthony J. Bleyer, MD, MS, Section on Nephrology, Bowman Gray School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157.
    Affiliations
    Departments of Internal Medicine and Public Health Sciences, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC USA

    Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway
    Search for articles by this author
  • Grethe S. Tell
    Affiliations
    Departments of Internal Medicine and Public Health Sciences, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC USA

    Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway
    Search for articles by this author
  • Gregory W. Evans
    Affiliations
    Departments of Internal Medicine and Public Health Sciences, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC USA

    Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway
    Search for articles by this author
  • Walter H. Ettinger Jr
    Affiliations
    Departments of Internal Medicine and Public Health Sciences, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC USA

    Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway
    Search for articles by this author
  • John M. Burkart
    Affiliations
    Departments of Internal Medicine and Public Health Sciences, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC USA

    Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      This study compared racial differences in end-stage renal disease (ESRD) in 550 patients starting renal replacement therapy at a large academic dialysis center between January 1, 1990, and December 31, 1993, with follow-up through December 31, 1994. Patient groups were compared with respect to cause of ESRD, comorbid factors at the start of dialysis therapy, choice of modality, transplantation rate, and survival. Fifty-eight percent of the patients were white and 42% were African-American. There was a similar distribution of causes of ESRD between races. African-American patients were less likely to choose peritoneal dialysis as initial therapy (11.6% v 29.3%; P < 0.001) and were less likely to change dialysis modality. Transplantation rates were significantly different between African-American and white patients (9.3% v 27.6%; P < 0.001). African-Americans less frequently received living-related, living-nonrelated, and cadaveric renal transplants. Given differences in transplantation rates and in survival of transplanted patients versus patients on dialysis, survival analysis was performed without censoring for transplantation. A multivariate Cox proportional hazards model was formed, and the following were identified as being significant independent predictors of survival: age, race, age-race interaction, serum albumin at the start of dialysis, activity level at the start of dialysis, and presence of congestive heart failure and cancer. Age had little effect on survival among African-American patients, while it was a significant predictor of survival in white patients. In the group of patients starting dialysis before the age of 30 years, African-American patients had a significantly increased mortality risk compared with white patients. However, white patients older than 50 years had a higher mortality risk; this risk difference increased with age. Racial differences in mortality among older white patients could not be explained by differences in comorbid conditions, transplantation rates, or withdrawal from dialysis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • United States Renal Data System
        USRDS 1994 Annual Data Report. National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, MD1994: 84
        • Feldman HI
        • Klag MJ
        • Chiapella AP
        • Whelton PK
        End-stage renal disease in US minority groups.
        Am J Kidney Dis. 1992; 19: 411-413
        • United States Renal Data System
        USRDS 1994 Annual Data Report. National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, MD1994: 119-124
        • Bloembergen WE
        • Port FK
        • Mauger EA
        • Wolfe RA
        Causes of death in dialysis patients: Racial and gender differences.
        J Am Soc Nephrol. 1994; 5: 1231-1242
        • Lowrie EG
        • Lew NL
        • Huang WH
        Race and diabetes as death risk predictors in hemodialysis patients.
        Kidney Int. 1992; 42: S22-S31
        • Held PJ
        • Port FK
        • Turenne MN
        • Gaylin DS
        • Hamburger RJ
        • Wolfe RA
        Continuous ambulatory peritoneal dialysis and hemodialysis: Comparison of patient mortality with adjustment for comorbid conditions.
        Kidney Int. 1994; 45: 1163-1169
        • Goldberg AP
        • Harter HR
        • Patsch W
        • Schechtman KB
        • Province M
        • Weerts MA
        • Kuisk I
        • McCrate MM
        • Schonfeld G
        Racial differences in plasma high-density lipoproteins in patients receiving hemodialysis.
        N Engl J Med. 1983; 308: 1245-1252
        • Garcia-Garcia G
        • Deddens JA
        • D'Achiardi-Rey R
        • First MR
        • Samuels SJ
        • Kant S
        • Pollak VE
        Results of treatment in patients with end-stage renal disease: A multivariate analysis of risk factors and survival in 341 successive patients.
        Am J Kidney Dis. 1985; 5: 10-18
        • Goldwasser P
        • Mittman N
        • Antignani A
        • Burrell D
        • Michel MA
        • Collier J
        • Avram MM
        Predictors of mortality in hemodialysis patients.
        J Am Soc Nephrol. 1993; 3: 1613-1622
        • McClellan WM
        • Flanders D
        • Gutman RA
        Variable mortality rates among dialysis treatment centers.
        Ann Intern Med. 1992; 117: 332-336
        • Lowrie EG
        • Lew NL
        Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities.
        Am J Kidney Dis. 1990; 15: 458-482
        • Port FK
        • Wolfe RA
        • Manger EA
        • Berling DP
        • Jiang K
        Comparison of survival probabilities for dialysis patients vs. cadaveric renal transplant recipients.
        JAMA. 1993; 270: 1339-1343
        • Gutman RA
        • Stead WW
        • Robinson RR
        Physical activity and employment status of patients on maintenance dialysis.
        N Engl J Med. 1981; 304: 309-313
        • Collins AJ
        • Ma JZ
        • Umen A
        • Keshaviah P
        Urea index and other predictors of hemodialysis survival.
        Am J Kidney Dis. 1994; 23: 272-282
        • Umen AJ
        • Le CT
        Prognostic factors, models, and related statistical problems in the survival of end-stage renal disease patients on hemodialysis.
        Stat Med. 1986; 5: 637-652
        • United States Renal Data System
        Incidence and causes of treated ESRD.
        Am J Kidney Dis. 1994; 24: S48-S56
        • Freedman BI
        • Iskandar SS
        • Appel RG
        The link between hypertension and nephrosclerosis.
        Am J Kidney Dis. 1995; 25: 207-221
        • Richards NT
        • Greaves I
        • Lee SJ
        • Howie AJ
        • Adu D
        • Michael J
        Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus.
        Nephrol Dial Transplant. 1992; 7: 397-399
        • Lynn KL
        • Frendin TJ
        • Walker RJ
        • Bailey RR
        • Swainson CP
        Renal disease in diabetics—Which patients have diabetic nephropathy and what is their outcome?.
        Aust N Z J Med. 1988; 18: 764-767
        • O'Neil EA
        • Hansen KJ
        • Canzanello VJ
        • Pennel TC
        • Dean RH
        Prevalence of ischemic nephropathy in patients with renal insufficiency.
        Am Surg. 1992; 58: 485-490
        • Gonwa TA
        • Hamilton RW
        • Buckalew VM
        Chronic renal failure and end-stage renal disease in North Carolina: Importance of analgesic-associated nephropathy.
        Arch Intern Med. 1981; 141: 462-465
        • O'Donovan RM
        • Gutierrez OH
        • Izzo JL
        Preservation of renal function by percutaneous renal angioplasty in high-risk elderly patients: Short-term outcome.
        Nephron. 1992; 60: 187-192
        • Maiorca R
        • Vonesh E
        • Cancarini C
        • Cantaluppi A
        • Mainili L
        • Brunori G
        • Camerini C
        • Feller P
        • Strada A
        A six-year comparison of patient and technique survivals in CAPD and HD.
        Kidney Int. 1988; 34: 518-524
        • Mailloux LU
        • Bellucci AG
        • Napolitano B
        • Mossey T
        • Wilkes BM
        • Bluestone PA
        Survival estimates for 683 patients starting dialysis from 1970 through 1989: Identification of risk factors for survival.
        Clin Nephrol. 1994; 42: 127-135
        • Hutchinson TA
        • Thomas DC
        • Lemieux JC
        • Harvey CE
        Prognostically controlled comparison of dialysis and renal transplantation.
        Kidney Int. 1984; 4: 44-51
        • Brogan D
        • Kutner NG
        • Flagg E
        Survival differences among older dialysis patients in the Southeast.
        Am J Kidney Dis. 1992; 20: 376-386
        • Held PJ
        • Pauly MV
        • Diamond L
        Survival analysis of patients undergoing dialysis.
        JAMA. 1987; 257: 645-650
        • Kurtin P
        • Nissenson AR
        Variation in ESRD patient outcomes: What we know, what should we know, and how do we find it out?.
        J Am Soc Nephrol. 1993; 3: 1738-1747
        • Conlon P
        • Krucoff M
        • Minda SA
        • Martin G
        • Schwab SJ
        Silent myocardial ischemia in ESRD patients.
        J Am Soc Nephrol. 1994; 5: 440
        • Freedman BI
        • Espeland MA
        • Heise ER
        • Adams PL
        • Buckalew VM
        • Canzanello VJ
        Racial differences in HLA antigen frequency and hypertensive renal failure.
        Am J Hypertens. 1991; 4: 393-398
        • Hypertension Detection and Follow-Up Program Cooperative Group
        JAMA. 1977; 237: 2385-2391
        • Hypertension Detection and Follow-up Program Cooperative Group
        JAMA. 1979; 242: 2562-2571